scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...732400L |
P356 | DOI | 10.1371/JOURNAL.PONE.0032400 |
P932 | PMC publication ID | 3302873 |
P698 | PubMed publication ID | 22427834 |
P5875 | ResearchGate publication ID | 221716245 |
P50 | author | Wendy Barclay | Q20005716 |
Munir Iqbal | Q61081409 | ||
Bryan Charleston | Q61162596 | ||
Simon Gubbins | Q41050267 | ||
Charlotte F Inman | Q56847568 | ||
Sharon M Brookes | Q56847574 | ||
Veronica Njie-Carr | Q57882897 | ||
P2093 | author name string | Ian H Brown | |
Mick Bailey | |||
Eric A Lefevre | |||
COSI | |||
Fanny Garcon | |||
Helen Prentice | |||
Michelle L Hill | |||
Ruth A Elderfield | |||
P2860 | cites work | Genetically determined CD45 variant of value in leucocyte tracing in vivo in the pig | Q71819231 |
Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes | Q83918132 | ||
Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs | Q40766135 | ||
The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses | Q42790878 | ||
Pathogenesis of highly pathogenic avian influenza A/turkey/Turkey/1/2005 H5N1 in Pekin ducks (Anas platyrhynchos) infected experimentally | Q43175308 | ||
The epidemiology and evolution of influenza viruses in pigs | Q43214794 | ||
Gene gun immunization in a preclinical model is enhanced by B7 targeting. | Q44455406 | ||
Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. | Q45419096 | ||
Efficacy of commercial swine influenza vaccines against challenge with a recent European H1N1 field isolate | Q49113490 | ||
Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals | Q22255464 | ||
Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes | Q24538783 | ||
Replication, pathogenesis and transmission of pandemic (H1N1) 2009 virus in non-immune pigs | Q27334919 | ||
Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study | Q28751886 | ||
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans | Q29619059 | ||
Cell-mediated protection in influenza infection. | Q30353071 | ||
Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. | Q30378835 | ||
A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models. | Q30386068 | ||
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection | Q30388857 | ||
Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus | Q30391898 | ||
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers | Q30395583 | ||
Long-term evolution and transmission dynamics of swine influenza A virus | Q30403142 | ||
Comparison of humoral and cellular immune responses to inactivated swine influenza virus vaccine in weaned pigs. | Q30403679 | ||
Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution | Q33692187 | ||
TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection | Q34807008 | ||
Protective B cell responses to flu--no fluke! | Q35158499 | ||
Haemagglutination-inhibiting antibody to influenza virus | Q35747515 | ||
Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
Lymphocyte development in fetal piglets: facts and surprises | Q36250144 | ||
Type I interferon as a stimulus for cross-priming | Q37027815 | ||
Vaccine-induced, pseudorabies virus-specific, extrathymic CD4+CD8+ memory T-helper cells in swine. | Q39580627 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunization | Q1415366 |
influenza vaccine | Q383260 | ||
P304 | page(s) | e32400 | |
P577 | publication date | 2012-03-09 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes | |
P478 | volume | 7 |
Q30421502 | Advances in the development of universal influenza vaccines |
Q30388110 | Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus. |
Q38067243 | Animal models for neonatal diseases in humans |
Q27325786 | Dietary Enterococcus faecium NCIMB 10415 and zinc oxide stimulate immune reactions to trivalent influenza vaccination in pigs but do not affect virological response upon challenge infection |
Q30394336 | Distinct immune responses and virus shedding in pigs following aerosol, intra-nasal and contact infection with pandemic swine influenza A virus, A(H1N1)09 |
Q35560718 | Impaired NK Cell Responses to Pertussis and H1N1 Influenza Vaccine Antigens in Human Cytomegalovirus-Infected Individuals |
Q30429455 | Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine |
Q30391724 | Influenza A Virus Infection in Pigs Attracts Multifunctional and Cross-Reactive T Cells to the Lung. |
Q37015056 | Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection. |
Q38492768 | Large animal models for vaccine development and testing. |
Q40603045 | Magnitude and kinetics of multifunctional CD4+ and CD8β+ T cells in pigs infected with swine influenza A virus |
Q30423733 | Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection |
Search more.